Giovannelli e Associati with Ardian on the joint acquisition, on an equal basis with NB Renaissance, of a majority stake in Neopharmed Gentili

Pubblicato da Giovannelli e Associati il 11/04/2023

Ardian and NB Renaissance have announced the finalization of their joint acquisition, on an equal basis, of a majority stake in the share capital of Neopharmed Gentili, a company formerly controlled by Ardian and in which the Mediolanum Farmaceutici Group held a minority stake. The transaction was announced in November.

Giovannelli e Associati assisted Ardian with a team led by partner Fabrizio Scaparro and consisting of senior associate Paola Pagani and associates Lilia Montella, Matteo Bruni and Filippo Noci.

Ardian – Neopharmed Gentili – Marketscreener – 31.03.2023

HOT LABOUR TOPICS – Also working fathers are entitled to NASpI indemnity should they voluntarily resign within the first year of their child’s life

Giovannelli e Associati recommended for five practice areas in The Legal 500 EMEA 2023 Edition

Giovannelli e Associati with Ardian on the joint acquisition, on an equal basis with NB Renaissance, of a majority stake in Neopharmed Gentili

Media correlati

Giovannelli e Associati with Nebula Aurea BidCo (White Bridge Investments III) on the voluntary all-inclusive offer on shares and warrants of Reevo

Giovannelli e Associati announces a round of promotions

Giovannelli e Associati awarded for the Venture Capital practice in 2022 in the context of the Class MF regional Awards, an initiative sponsored by Class Editori